Although this mechanism has yet to be investigated in HGSC, elevated expression of ALK protein was reported in 28% of HGSC samples (independent of ALK mutation or gene rearrangement), providing one potential mechanism for MYCN up-regulation in the tumor microenvironment (47, 48). The gene discussed is ALK; the disease is neoplasm.